Curie Oncology
About Curie Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Arcus Biosciences, Inc.
1
Celcuity, Inc.
1
Hoffmann-La Roche
1
Shanghai Junshi Bioscience Co., Ltd.
1
Zymeworks Inc.
1
Clinical Trials at Curie Oncology
During the past decade, Curie Oncology conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Monotherapy and Combination Immunotherapies in Participants With PD-L1 Positive Non-small Cell Lung Cancer
2020-05-28
2024-02-01
Active, not recruiting
151
Evaluate the Safety and Efficacy of Toripalimab Combined With Bevacizumab Versus Sorafenib Therapy for HCC
2020-10-15
2024-12-31
Active, not recruiting
326
A Study of Lomvastomig (RO7121661) and Tobemstomig (RO7247669) Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus
2021-06-25
2025-06-30
Recruiting
210
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
2021-12-02
2025-07-01
Recruiting
714
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
2022-09-30
2026-09-30
Recruiting
701
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Curie Oncology" #1 sponsor was "Arcus Biosciences, Inc." with 1 trials, followed by "Celcuity, Inc." with 1 trials
sponsored, "Hoffmann-La Roche" with 1 trials sponsored, "Shanghai Junshi Bioscience Co., Ltd." with 1 trials sponsored and "Zymeworks Inc."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Curie Oncology"
#1 collaborator was "BeiGene, Ltd." with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Curie Oncology
According to Clinical.Site data, the most researched conditions in "Curie Oncology" are
"Advanced Hepatocellular Carcinoma (HCC)" (1 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "Breast Cancer" (1 trials), "Esophageal Adenocarcinoma" (1 trials) and "Gastric Neoplasms" (1 trials). Many other conditions were trialed in "Curie Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Curie Oncology
Most popular intervention types in "Curie Oncology" are "Drug" (5 trials), "Combination Product" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "5-Fluorouracil" (1 trials), "Alpelisib" (1 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials) and "Domvanalimab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Curie Oncology
The vast majority of trials in "Curie Oncology" are
5 trials for "All" genders.
Clinical Trials Status at Curie Oncology
Currently, there are NaN active trials in "Curie Oncology".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Curie Oncology,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Curie Oncology, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".